BOHLIN GAREN G
SEC Form 4 insider trading activity
BOHLIN GAREN G has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including KPTI, COLL, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: May 26, 2026.
On the most recent filing, BOHLIN GAREN G is listed as Director at COLLEGIUM PHARMACEUTICAL, INC. Inside the rolling window, BOHLIN GAREN G reported no open-market purchases and 1 open-market sale totaling $323K in COLL.
Companies traded
Other insiders at KPTI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$323K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has BOHLIN GAREN G made?
BOHLIN GAREN G has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including KPTI, COLL since 2026.
Which companies does BOHLIN GAREN G trade?
BOHLIN GAREN G has filed SEC Form 4 disclosures for 2 companies, including KPTI, COLL.
When was BOHLIN GAREN G's most recent SEC Form 4 filing?
BOHLIN GAREN G's most recent SEC Form 4 filing on Tracefour is dated May 26, 2026.
What is BOHLIN GAREN G's total buy and sell value in the current window?
Inside the rolling retention window, BOHLIN GAREN G bought $0 and sold $323K based on SEC Form 4 filings.
What was BOHLIN GAREN G's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 8,700 COLL shares on 2026-05-11, worth $323K, per SEC Form 4 filings.